Abbott Laboratories (ABT) call put ratio 2.86 calls to 1 put into Q3
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Abbott Labs (ABT) PT Raised to $65 at Jefferies
October 19, 2017 9:25 AM EDTJefferies raised its price target on Abbott Labs (NYSE: ABT) to $65.00 (from $58.00) while maintaining a Buy rating following the company's 3Q earnings report. Org growth in 3Q of +5.6% was the best in 2 years and largely validates the recent portfolio moves. Driving the performance... More
Abbott Labs (ABT) PT Raised to $63 at Stifel Following 3Q Release
October 18, 2017 5:06 PM EDTStifel raised its price target on Abbott Labs (NYSE: ABT) to $63.00 (from $58.00) while maintaining a Buy rating following the company's 3Q earnings report. The company reported above-expectation 5.6% comparable operational sales growth and above-consensus EPS at $0.66 (vs. $0.65 Consensus). positive 3Q highlights included: key product approvals, improving pipeline... More
